Abrogation of autoimmune diabetes in nonobese diabetic mice and protection against effector lymphocytes by transgenic paracrine TGF-β1

Journal of Clinical Investigation

Volumn 102, Issue 3, 1998, Pages 499-506

  Moritani, Maki ^a   Yoshimoto, Katsuhiko ^a   Wong, Susan F ^b   Tanaka, Chisato ^a   Yamaoka, Takashi ^a   Sano, Toshiaki ^a   Komagata, Yoshinori ^c   Miyazaki, Jun Ichi ^d   Kikutani, Hitoshi ^e   Itakura, Mitsuo ^a,f  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TOHOKU UNIVERSITY   (Japan)

^d OSAKA UNIVERSITY   (Japan)

^e OSAKA UNIVERSITY   (Japan)

^f UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Adoptive transfer; CD4+ and CD8+ T cells; Nonobese diabetic (NOD) mice; Pancreatic islets; Rat glucagon promoter (RGP)

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; TRANSFORMING GROWTH FACTOR BETA1;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DIABETES MELLITUS; HISTOPATHOLOGY; IMMUNOMODULATION; IMMUNOPATHOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 18544392433     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI2992     Document Type: Article

References (39)

1. Tisch, R., and H. McDevitt. 1996. Insulin-dependent diabetes mellitus. Cell. 85:291-297.
2. Kikutani, H., and S. Makino. 1992. The murine autoimmune diabetes model: NOD and related strains. Adv. Immunol. 51:285-321.
3. Kehrl, J.H., L.M. Wakefield, A.B. Roberts, S. Jakewlew, M. Alvarez-Mon, R.B.S.M. Derynck, and A.S. Fauci. 1986. Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth. J. Exp. Med. 163:1037-1050.
4. Kehrl, J.H., A.B. Roberts, L.M. Wakefield, S. Jakewlew, M.B. Sporn, and A.S. Fauci. 1986. Transforming growth factor β is an important immunomodulatory protein for human B lymphocytes. J. Immunol. 137:3855-3860.
5. Rook, A.H., J.H. Kehrl, L.M. Wakefield, A.B. Roberts, M.B. Sporn, D.B. Burlington, H.C. Lane, and A.S. Fauci. 1986. Effects of transforming growth factor-β on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness. J. Immunol. 136:3916-3920.
6. Espevik, T., I.S. Figari, M.R. Shalaby, G.A. Lackides, G.D. Lewis, H.M. Shepard, and M.A. Palladino, Jr. 1987. Inhibition of cytokine production by cyclosporin A and transforming growth factor β. J. Exp. Med. 166:571-576.
7. Chantry, D., M. Turner, E. Abney, and M. Feldman. 1989. Modulation of cytokine production by transforming growth factor-β1. J. Immunol. 142:4295-4300.
8. Shull, M.M., I. Ormsby, A.B. Kier, S. Pawlowski, R.J. Diebold, M. Yin, R. Allen, C. Sidman, G. Proetzel, D. Calvin, N. Annunziata, and T. Doetschman. 1992. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature. 359:693-699.
9. Kulkarni, A.B., C.G. Huh, D. Becker, A. Geiser, M. Lyght, K.C. Flanders, A.B. Roberts, M.B. Sporn, J.M. Ward, and S. Karlsson. 1993. Transforming growth factor β1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. USA. 90:770-774.
10. Kiefer, R., K. Funa, T. Schweitzer, S. Jung, O. Bourde, K.V. Toyka, and H.P. Hartung. 1996. Transforming growth factor-beta 1 in experimental autoimmune neuritis. Cellular localization and time course. Am. J. Pathol. 148: 211-223.
11. Kulluvilla, A.P., R. Shah, G.M. Hochwald, H.D. Liggitt, M.A. Palladino, and G.J. Thorbecke. 1991. Protective effect of transforming growth factor β1 on experimental autoimmune diseases in mice. Proc. Natl. Acad. Sci. USA. 88: 2918-2921.
12. Racke, M.K., S. Dhib-Jalbut, B. Canella, P.S. Albert, C.S. Raine, and D.E. Macfarlin. 1992. Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-β1. J. Immunol. 146:3012-3017.
13. Miller, A., O. Lider, A.B. Roberts, M.B. Sporn, and H.L. Weiner. 1992. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune response by the release of transforming growth factor β after antigen-specific triggering. Proc. Natl. Acad. Sci. USA. 89: 421-425.
14. Chen, Y., V.K. Kuchroo, J. Inobe, D.A. Hafler, and H.L. Weiner. 1994. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science. 265:1237-1240.
15. + cells mediate active suppression. J. Immunol. 155:910-916.
16. Friedman, A., and H.L. Weiner. 1994. Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc. Natl. Acad. Sci. USA. 91:6688-6692.
17. Fukaura, H., S.C. Kent, M.J. Pietrusewicz, S.J. Khoury, H.L. Weiner, and D.A. Hafler. 1996. Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta 1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. J. Clin. Invest. 98: 70-77.
18. Von-Herrath, M.G., T. Dyrberg, and M.B. Oldstone. 1996. Oral insulin treatment suppresses virus-induced antigen-specific destruction of beta cells and prevents autoimmune diabetes in transgenic mice. J. Clin. Invest. 98:1324-1331.
19. Mueller, R., T. Krahl, and N. Sarvetnick. 1996. Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetes (NOD) mice. J. Exp. Med. 184:1093-1099.
20. Lee, M.-S., D. Gu, L. Feng, S. Curriden, M. Arnush, T. Krahl, D. Gurushanthaiah, C. Wilson, D.L. Loskutoff, H. Fox, and N. Sarvetnick. 1995. Accumulation of extracellular matrix and developmental dysregulation in the pancreas by transgenic production of transforming growth factor-β1. Am. J. Pathol. 147:42-52.
21. Sanvito, F., A. Nichols, P.L. Herrera, J. Huarte, A. Wohlwend, J.D. Vassalli, and L. Orci. 1995. TGF-β1 overexpression in murine pancreas induces chronic pancreatis and, together with TNF-α, triggers insulin-dependent diabetes. Biochem. Biophys. Res. Commun. 217:1279-1286.
22. Lee, M.-S., S. Stephen, M. Arnush, T. Krahl, M. von-Herrath, M.B. Oldstone, and N. Sarvetnick. 1996. Transforming growth factor-β fails to inhibit allograft rejection or virus-induced autoimmune diabetes in transgenic mice. Transplantation. 61:1112-1113.
23. Wahl, S.M. 1992. Transforming growth factor beta (TGF-β) in inflammation: a cause and cure. J. Clin. Immunol. 12:61-74.
24. Brunner, A.M., H. Marquardt, A.R. Malacko, M.N. Lioubin, and A.F. Purchio. 1989. Site-directed mutagenesis of cysteine residues in the pro-region of the transforming growth factor-β1 precursor. Expression and characterization of mutant proteins. J. Biol. Chem. 264:13660-13664.
25. Samuel, S.K., R.A.R. Hurta, P. Kondaiah, N. Khalil, E. Turley, J.A. Wright, and A.H. Greenberg. 1992. Autocrine induction of tumor protease production and invasion by a metallothionein-regulated TGF-β1 (Ser223, 225). EMBO (Eur. Mol. Biol. Organ.) J. 11:1599-1605.
26. Moritani, M., K. Yoshimoto, F. Tashiro, C. Hashimoto, J. Miyazaki, S. Ii, E. Kudo, H. Iwahana, Y. Hayashi, T. Sano, and M. Itakura. 1994. Transgenic expression of IL-10 in pancreatic islet A cells accelerates autoimmune insulitis and diabetes in non-obese diabetic mice. Int. Immunol. 6:1927-1936.
27. Efrat, S., G. Teitelman, M. Anwar, D. Ruggiero, and D. Hanahan. 1988. Glucagon gene regulatory region directs oncoprotein expression to neurons and pancreatic α cells. Neuron. 1:605-613.
28. Moritani, M., K. Yoshimoto, S. Ii, M. Kondo, H. Iwahana, T. Sano, N. Nakano, H. Kikutani, and M. Itakura. 1996. Prevention of adoptively transferred diabetes in nonobese diabetic mice with IL-10-transduced islet-specific Th1 lymphocytes. A gene therapy model for autoimmune diabetes. J. Clin. Invest. 98:1851-1859.
29. Ikeda, T., M.N. Lioubin, and H. Marquardt. 1987. Human transforming growth factor type beta 2: production by a prostatic adenocarcinoma cell line, purification, and initial characterization. Biochemistry. 26:2406-2410.
30. Nakano, N., H. Kikutani, H. Nishimoto, and T. Kishimoto. 1991. T cell receptor v gene usage of islet β cell-reactive T cells is not restricted in nonobese diabetic mice. J. Exp. Med. 173:1091-1097.
31. + cells. J. Exp. Med. 183: 67-76.
32. Kopp, J.B., V.M. Factor, M. Mozes, P. Nagy, N. Sanderson, E.P. Bottinger, P.E. Klotman, and S.S. Thorgeirsson. 1996. Transgenic mice with increased plasma levels of TGF-beta 1 develop progressive renal disease. Lab. Invest. 74:991-1003.
33. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature. 389:737-742.
34. + T cell clone, I.S. 2.15, has in vitro immunosuppressive properties. Eur. J. Immunol. 22:2017-2023.
35. + suppressor T cell completely prevents spontaneous autoimmune diabetes and recurrent diabetes in syngeneic islet-transplanted NOD mice. J. Autoimmun. 9:331-339.
36. + T cells, interleukin 4 production is cytokine-autonomous, whereas interferon gamma production is cytokine-dependent. Proc. Natl. Acad. Sci. USA. 94: 3189-3194.
37. Nakamura, T., R.K. Lee, S.Y. Nam, E.R. Podack, K. Bottomly, and R.A. Flavell. 1997. Roles of IL-4 and IFN-gamma in stabilizing the T helper cell type 1 and 2 phenotype. J. Immunol. 158:2648-2653.
38. + T cells. J. Immunol. 158:1085-1094.
39. Shaw, M.K., J.B. Lorens, A. Dhawan, R. DalCanto, H.Y. Tse, A.B. Tran, C. Bonpane, S.L. Eswaran, S. Brocke, N. Sarvetnick, et al. 1997. Local delivery of interleukin 4 by retrovirus-transduced T lympocytes ameliorates experimental autoimmune encephalomyelitis. J. Exp. Med. 185:1711-1714.